These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24024678)

  • 61. Comparative evaluation of topical calcipotriol versus coal tar and salicylic acid ointment in chronic plaque psoriasis.
    Singh P; Gupta S; Abidi A; Krishna A
    J Drugs Dermatol; 2013 Aug; 12(8):868-73. PubMed ID: 23986159
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study.
    Rich P; Sigurgeirsson B; Thaci D; Ortonne JP; Paul C; Schopf RE; Morita A; Roseau K; Harfst E; Guettner A; Machacek M; Papavassilis C
    Br J Dermatol; 2013 Feb; 168(2):402-11. PubMed ID: 23362969
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Topical treatment of psoriasis with dithranol.
    Farber EM
    Acta Derm Venereol Suppl (Stockh); 1984; 112():11-6. PubMed ID: 6596820
    [No Abstract]   [Full Text] [Related]  

  • 65. Treatment of psoriasis in general practice with short contact dithranol.
    Blomfield I; Sedcole V; Cunliffe WJ
    Practitioner; 1985 Jul; 229(1405):637-41. PubMed ID: 4034473
    [No Abstract]   [Full Text] [Related]  

  • 66. [Effect of the treatment of psoriasis with dithranol in comparison with a combination of dithranol and a corticosteroid].
    Gloor M; Graf R; Wirth H; Landau M
    Hautarzt; 1983 Oct; 34(10):500-3. PubMed ID: 6643055
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years.
    Kimball AB; Gordon KB; Fakharzadeh S; Yeilding N; Szapary PO; Schenkel B; Guzzo C; Li S; Papp KA
    Br J Dermatol; 2012 Apr; 166(4):861-72. PubMed ID: 22356258
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intermittent etanercept therapy in pediatric patients with psoriasis.
    Siegfried EC; Eichenfield LF; Paller AS; Pariser D; Creamer K; Kricorian G
    J Am Acad Dermatol; 2010 Nov; 63(5):769-74. PubMed ID: 20833444
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment of moderate-to-severe psoriasis with alefacept for up to one year: a case series.
    Shah A; O'Neill J; Feldman SR
    J Drugs Dermatol; 2010 Dec; 9(12):1491-4. PubMed ID: 21120256
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficacy of topical dithranol (Dithrocream
    Daunton A; Harries M
    Br J Dermatol; 2019 May; 180(5):1246-1247. PubMed ID: 30536990
    [No Abstract]   [Full Text] [Related]  

  • 71. Clinical effectiveness and safety experience with alefacept in the treatment of patients with moderate-to-severe chronic plaque psoriasis in Taiwan: results of an open-label, single-arm, multicentre pilot study.
    Huang PH; Liao YH; Wei CC; Tseng YH; Ho JC; Tsai TF
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):923-30. PubMed ID: 18312328
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A novelliposomal formulation of dithranol for psoriasis: preliminary results.
    Agarwal R; Saraswat A; Kaur I; Katare OP; Kumar B
    J Dermatol; 2002 Aug; 29(8):529-32. PubMed ID: 12227489
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy of a day-care program in the treatment of psoriasis.
    Zhang J; Adam DN; Stebbing E; Gerbrandt J; Lui H; Shapiro J; Zhou Y
    J Cutan Med Surg; 2008; 12(5):211-6. PubMed ID: 18845089
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An open assessment of 0.1% dithranol in a 17% urea base ('Psoradrate' 0.1%) in the treatment of psoriasis of children.
    Guerrier CJ; Porter DI
    Curr Med Res Opin; 1983; 8(6):446-50. PubMed ID: 6342960
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Maintenance therapy of psoriasis].
    Wohlrab J
    Hautarzt; 2006 Aug; 57(8):661-5. PubMed ID: 16788778
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The relevance of salicylic acid in the treatment of plaque psoriasis with dithranol creams.
    de Mare S; Calis N; den Hartog G; van Erp PE; van de Kerkhof PC
    Skin Pharmacol; 1988; 1(4):259-64. PubMed ID: 2483115
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Short-contact dithranol therapy.
    Sharpe G; Farr PM
    Br J Dermatol; 1986 Apr; 114(4):518-9. PubMed ID: 3964552
    [No Abstract]   [Full Text] [Related]  

  • 78. Twice-daily vs. once-daily inpatient dithranol for psoriasis.
    Kirkup ME; Sabroe RA; Kavanagh GM; Downs AM; Sansom JE; de Berker DA; Dunnill MG; Kennedy CT; Archer CB
    Clin Exp Dermatol; 2002 Nov; 27(8):695-9. PubMed ID: 12472549
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Skin irritation by dithranol cream. A blind study to assess the role of the cream formulation.
    Prins M; Swinkels OQ; Kolkman EG; Wuis EW; Hekster YA; van der Valk PG
    Acta Derm Venereol; 1998 Jul; 78(4):262-5. PubMed ID: 9689292
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Short contact dithranol therapy--twice daily and high concentration regimes.
    Statham BN; Rowell NR
    Br J Dermatol; 1985 Aug; 113(2):245-6. PubMed ID: 4027191
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.